Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2025 ∙ Zhao, T. Xu, Q. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.
Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Magalhaes, B. A. P. Medeiros Minasi, J. Lobato, R. C. Lemos, L. C. de Britto, L. S. Barros, R. M. de Martinez, A. M. B. da Hora, V. P.
Globally approved vaccines for COVID-19: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Zhang, C. Zhang, Y. Q. Liu, R. B. Ma, Y. T. Zhao, L. K. Yin, F. Q. Tu, J. Yao, Y. Y.
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Hoang, T. N. A. Byrne, A. Quach, H. L. Bannister-Tyrrell, M. Vogt, F.
How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis
Adults Older adults Pneumococcal disease Influenza COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Ballivian, J. Parker, E. P. K. Berrueta, M. Ciapponi, A. Argento, F. Bardach, A. Brizuela, M. Castellana, N. Comande, D. Kampmann, B. Mazzoni, A. Sambade, J. M. Stegelmann, K. Xiong, X. Munoz, F. M. Stergachis, A. Buekens, P.
Immunogenicity of COVID-19 Vaccines During Pregnancy A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2025 ∙ Bushi, G. Gaidhane, A. M. Vadia, N. Menon, S. V. Chennakesavulu, K. Panigrahi, R. Shabil, M. Jena, D. Kumar, H. Rani, A. Sah, S. Rohilla, S. Singh, M. P. Goh, K. W.
Impact of COVID-19 Vaccination on Menstrual Irregularities, Bleeding Patterns, and Cycle Duration: A Systematic Review and Meta-Analysis
Adolescents Adults COVID-19 Safety
Rating:
Low
2025 ∙ Sumsuzzman, D. M. Ye, Y. Wang, Z. Pandey, A. Langley, J. M. Galvani, A. P. Moghadas, S. M.
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
High
2025 ∙ Pan, B. Y. Tseng, I. S. Feng, Y. C. Fang, C. T.
Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Loddo, F. Lagana, P. Rizzo, C. E. Calderone, S. M. Romeo, B. Venuto, R. Maisano, D. Fedele, F. Squeri, R. Nicita, A. Nirta, A. Genovese, G. Bartucciotto, L. Genovese, C.
Intestinal Microbiota and Vaccinations: A Systematic Review of the Literature
All age groups COVID-19 Salmonella Cholera Rotavirus Efficacy/effectiveness Safety
Rating:
Critically low
Loading...